NHS Framework for the North of England, Branded Medicine
Details
- Buyer
- NHS England
- Supplier(s)
30 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Amgen Ltd
- Astra Zeneca UK Limited
- Bayer Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Celltrion Healthcare United Kingdom Ltd
- CST Pharma Limited
- Eli Lilly and Company Ltd
- GEDEON RICHTER (UK) LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- GLAXOSMITHKLINE UK LIMITED
- Ipsen
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Mylan
- Napp Pharmaceuticals Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Pfizer Liimted
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Teva UK Ltd
- Thornton and Ross
- UCB Pharma Ltd
- UL Global Pharma
- Zentiva Pharma UK Ltd
- Value
- £238,913,892
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 1 March 2022
- Source
- uk:contracts_finder
Tender description
Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Timeline
- Completed: Award published1 March 2022Current notice
- Completed: Award date1 March 2022
- Completed: Contract expiry date29 February 2024
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
12 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Generic Drugs - Oral Liquids
- Open tender
Injection Equipment Paraphernalia
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related topics
Topics related to NHS Framework for the North of England, Branded Medicine, ranked by notice volume.
- 1,704£212.9bn
Related buyers
Buyers similar to NHS England.
- 512£244.7m
- 448£1.6bn
- 407£112.7m
- 404£2.0bn
- 326£1.2bn
- 322£24.6bn
- 291£1.6bn
- 248£3.1bn
- 156£125.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.